Zhang, Jiejia. “FDX1 Is a Potential Prognostic Biomarker Related to Cuproptosis and Immune Infiltration for Patients With Kidney Clear Cell Carcinoma”. Annals of King Edward Medical University, vol. 30, no. 4, Dec. 2024, pp. 334-43, doi:10.21649/akemu.v30i4.5531.